ES8302462A1 - "un metodo para obtener una preparacion de insulina". - Google Patents
"un metodo para obtener una preparacion de insulina".Info
- Publication number
- ES8302462A1 ES8302462A1 ES82510245A ES510245A ES8302462A1 ES 8302462 A1 ES8302462 A1 ES 8302462A1 ES 82510245 A ES82510245 A ES 82510245A ES 510245 A ES510245 A ES 510245A ES 8302462 A1 ES8302462 A1 ES 8302462A1
- Authority
- ES
- Spain
- Prior art keywords
- magnesium
- production
- calcium
- insulin
- insulin preparations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 6
- 102000004877 Insulin Human genes 0.000 abstract 3
- 108090001061 Insulin Proteins 0.000 abstract 3
- 229940125396 insulin Drugs 0.000 abstract 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 2
- 229910052791 calcium Inorganic materials 0.000 abstract 2
- 239000011575 calcium Substances 0.000 abstract 2
- 239000011777 magnesium Substances 0.000 abstract 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 abstract 1
- 229910001424 calcium ion Inorganic materials 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 229910001425 magnesium ion Inorganic materials 0.000 abstract 1
- 159000000003 magnesium salts Chemical class 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Dental Preparations (AREA)
Abstract
METODO PARA OBTENER UNA PREPARACION DE INSULINA, ADECUADA PARA UTILIZARLA EN SISTEMAS DE SUMINISTRO DE INSULINA. SE DISUELVE LA INSULINA, JUNTO CON CALCIO O MAGNESIO EN FORMA ESENCIALMENTE IONIZABLE, EN UNA CONCENTRACION SUFICIENTE PARA COMUNICAR A DICHA SOLUCION LA ESTABILIDAD FISICA NECESARIA, PERO INSUFICIENTE PARA INDUCIR LA PRECIPITACION DE INSULINA EN ELLA, EN LAS CONDICIONES NORMALES. DESPUES SE AÑADE UN AGENTE DE CONSERVACION Y, OPCIONALMENTE, UN AGENTE NO IONIZANTE REGULADOR DE LA PRESION OSMOTICA Y/O UN AGENTE TAMPONADOR DEL PH QUE NO FORMA COMPLEJO NI COMPUESTOS LIGERAMENTE SOLUBLES CON LOS IONES CALCIO O MAGNESIO.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8107423 | 1981-03-10 | ||
| DK414381 | 1981-09-18 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8302462A1 true ES8302462A1 (es) | 1983-01-16 |
| ES510245A0 ES510245A0 (es) | 1983-01-16 |
Family
ID=26067363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES82510245A Granted ES510245A0 (es) | 1981-03-10 | 1982-03-09 | "un metodo para obtener una preparacion de insulina". |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4472385A (es) |
| EP (1) | EP0060141B1 (es) |
| AT (1) | ATE23269T1 (es) |
| AU (1) | AU550068B2 (es) |
| CA (1) | CA1170990A (es) |
| CH (1) | CH652031A5 (es) |
| DE (1) | DE3274064D1 (es) |
| ES (1) | ES510245A0 (es) |
| FI (1) | FI78838C (es) |
| FR (1) | FR2501507B1 (es) |
| GB (1) | GB2094145B (es) |
| IE (1) | IE52904B1 (es) |
| IT (1) | IT1150639B (es) |
| NO (1) | NO157843C (es) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1985002544A1 (en) * | 1983-12-16 | 1985-06-20 | Thomas Takemi Aoki | Insulin delivery algorithm |
| PH23446A (en) * | 1986-10-20 | 1989-08-07 | Novo Industri As | Peptide preparations |
| ES2053723T3 (es) * | 1987-02-25 | 1994-08-01 | Novo Nordisk As | Nuevos derivados de insulina. |
| US4789660A (en) * | 1987-09-10 | 1988-12-06 | American Home Products Corporation | Insulin administration using methyl and propyl paraben |
| HU228094B1 (en) † | 1996-06-20 | 2012-10-29 | Novo Nordisk As | Insulin preparations containing nacl |
| AR012894A1 (es) * | 1997-06-13 | 2000-11-22 | Lilly Co Eli | Formulacion de insulina en solucion estable, su uso para preparar un medicamento y proceso para la preparacion de la misma. |
| DE69924232D1 (de) * | 1998-01-09 | 2005-04-21 | Novo Nordisk As | Stabilisierte insulin-zubereitungen |
| US20020156434A1 (en) * | 1998-03-13 | 2002-10-24 | Minimed Inc. | Stabilizing catheter for protein drug delivery |
| WO2003094956A1 (en) | 2002-05-07 | 2003-11-20 | Novo Nordisk A/S | Soluble formulations comprising monomeric insulin and acylated insulin |
| US20030226223A1 (en) | 2002-06-11 | 2003-12-11 | The Procter & Gamble Co. | High efficiency electric toothbrush |
| US7322066B2 (en) | 2003-07-16 | 2008-01-29 | Church & Dwight Co., Inc. | Electric toothbrushes having movable, intermittently movable, and fixed bristles |
| US20050050659A1 (en) | 2003-09-09 | 2005-03-10 | The Procter & Gamble Company | Electric toothbrush comprising an electrically powered element |
| US20050053895A1 (en) | 2003-09-09 | 2005-03-10 | The Procter & Gamble Company Attention: Chief Patent Counsel | Illuminated electric toothbrushes emitting high luminous intensity toothbrush |
| FR2896164B1 (fr) * | 2006-01-18 | 2008-07-04 | Flamel Technologies Sa | Formulation colloidale d'insuline longue action et sa preparation |
| FR2943538B1 (fr) * | 2009-03-27 | 2011-05-20 | Adocia | Formulation a action rapide d'insuline recombinante humaine |
| US9018190B2 (en) | 2009-03-27 | 2015-04-28 | Adocia | Functionalized oligosaccharides |
| US20130231281A1 (en) | 2011-11-02 | 2013-09-05 | Adocia | Rapid acting insulin formulation comprising an oligosaccharide |
| EP2919804B1 (fr) | 2012-11-13 | 2018-01-31 | Adocia | Formulation à action rapide d'insuline comprenant un composé anionique substitué |
| WO2015120457A1 (en) * | 2014-02-10 | 2015-08-13 | Biodel Inc. | Stabilized ultra-rapid-acting insulin formulations |
| US9795678B2 (en) | 2014-05-14 | 2017-10-24 | Adocia | Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound |
| FR3020947B1 (fr) | 2014-05-14 | 2018-08-31 | Adocia | Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations |
| FR3043557B1 (fr) | 2015-11-16 | 2019-05-31 | Adocia | Composition a action rapide d'insuline comprenant un citrate substitue |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR892194A (fr) * | 1938-06-29 | 1944-03-30 | Ig Farbenindustrie Ag | Procédé de fabrication de préparations à base d'insuline |
| US2474729A (en) * | 1945-01-03 | 1949-06-28 | Rhone Poulenc Sa | Insulin preparations |
| US3102077A (en) * | 1953-08-19 | 1963-08-27 | Christensen Henry Marinus | Preparation of insulin containing 2.75 to 8 percent zinc content |
| DK98342C (da) * | 1959-06-16 | 1964-03-31 | Henry Marinus Dr Christensen | Fremgangsmåde til fremstilling af et insulinpræparat til peroral applikation. |
| US4196196A (en) * | 1978-06-19 | 1980-04-01 | Tiholiz Ivan C | Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states |
-
1982
- 1982-03-04 AU AU81114/82A patent/AU550068B2/en not_active Ceased
- 1982-03-09 FI FI820808A patent/FI78838C/fi not_active IP Right Cessation
- 1982-03-09 CH CH1447/82A patent/CH652031A5/de not_active IP Right Cessation
- 1982-03-09 AT AT82301207T patent/ATE23269T1/de not_active IP Right Cessation
- 1982-03-09 EP EP82301207A patent/EP0060141B1/en not_active Expired
- 1982-03-09 GB GB8206899A patent/GB2094145B/en not_active Expired
- 1982-03-09 CA CA000397937A patent/CA1170990A/en not_active Expired
- 1982-03-09 IT IT8220038A patent/IT1150639B/it active
- 1982-03-09 NO NO820742A patent/NO157843C/no unknown
- 1982-03-09 DE DE8282301207T patent/DE3274064D1/de not_active Expired
- 1982-03-09 IE IE536/82A patent/IE52904B1/en not_active IP Right Cessation
- 1982-03-09 ES ES82510245A patent/ES510245A0/es active Granted
- 1982-03-09 FR FR8203942A patent/FR2501507B1/fr not_active Expired
- 1982-03-09 US US06/356,343 patent/US4472385A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0060141A2 (en) | 1982-09-15 |
| FI820808L (fi) | 1982-09-11 |
| FI78838B (fi) | 1989-06-30 |
| NO820742L (no) | 1982-09-13 |
| GB2094145B (en) | 1984-12-05 |
| CH652031A5 (de) | 1985-10-31 |
| NO157843C (no) | 1988-06-01 |
| CA1170990A (en) | 1984-07-17 |
| FI78838C (fi) | 1989-10-10 |
| GB2094145A (en) | 1982-09-15 |
| US4472385A (en) | 1984-09-18 |
| AU550068B2 (en) | 1986-02-27 |
| NO157843B (no) | 1988-02-22 |
| AU8111482A (en) | 1982-09-16 |
| FR2501507B1 (es) | 1986-04-18 |
| ES510245A0 (es) | 1983-01-16 |
| ATE23269T1 (de) | 1986-11-15 |
| DE3274064D1 (en) | 1986-12-11 |
| IE820536L (en) | 1982-09-10 |
| EP0060141A3 (en) | 1983-08-24 |
| IT8220038A0 (it) | 1982-03-09 |
| IT1150639B (it) | 1986-12-17 |
| FR2501507A1 (es) | 1982-09-17 |
| EP0060141B1 (en) | 1986-11-05 |
| IE52904B1 (en) | 1988-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU550068B2 (en) | Zinc insulin stabilized with calcium or magnesium salts | |
| SE8300598D0 (sv) | Stabilized insulin solutions and method for their production | |
| ES8504678A1 (es) | Procedimiento para la preparacion de un derivado de insulina | |
| PL265078A1 (en) | A method of new pharmaceutical agents production with a prolonged time of active matter release | |
| GR970300038T1 (en) | Filtration | |
| EP0339486A3 (en) | Ester of ascorbic acid 2-phosphate | |
| ES2043601T3 (es) | Uso de acido gamma-linolenico y compuestos relacionados para la fabricacion de un medicamento para el tratamiento de complicaciones de la diabetes mellitus. | |
| PT85949A (en) | Process for the preparation of insulin compositions containing magnesium ions | |
| GR3030124T3 (en) | Derivatives of cyclohexane, preparations containing them and their use | |
| AU576204B2 (en) | Aqueous, injectable solutions of cis-platimum | |
| ES425303A1 (es) | Un procedimiento de fabricacion de sales de heparina sim- ples. | |
| EP0291863A3 (en) | Mixed crystals of insulin and insulin derivatives, their process of manufacture, pharmaceutical agents containing them and their use in the treatment of diabetes mellitus | |
| ZA773259B (en) | Improvements in or relating to methods for reducing the doses of biologically active substances while maintaining the biological effects | |
| JPS56106594A (en) | Stabilizing method of plasminogen | |
| JPS57206608A (en) | Production of gamma-globulin for intravenous injection | |
| AU618896B2 (en) | Stable solutions of rebeccamycin analog and preparation thereof | |
| HUT47600A (en) | Process for production of encephalinase glykopeptids, amin acid derivatives with hindering effect and medical compositions containing them | |
| EP0169320A3 (en) | Iodine-containing germicidal preparations and method of controlling and determining germicidal activity | |
| Brzin | Further observations of changed growth of Listeria monocytogenes on salt agar | |
| HUT41372A (en) | Herbicide compositions containing 7-/aryloxy/-2-naphtyloxy-alkane-carboxylic acid derivatives as active agents and process for producing the active agents | |
| JPS5762218A (en) | Ophthalmic solution | |
| IE38514L (en) | Insulin preparations. | |
| JPS57188511A (en) | Stabilized electrolyte solution | |
| ES8303441A1 (es) | Procedimiento de preparacion de soluciones estables de lipo-proteinas | |
| HUT46212A (en) | Process for production of antibacterial liofilized compounds |